Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine With Albumin Versus Albumin Alone in Hepatic Hydrothorax
NCT03645642Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of midodrine in Hepatic hydrothorax (HH) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Change in frequency of thoracentesis at 3 months. Started Sep 2018; status: completed.
02
Drugs
midodrine
03
Conditions
Hepatic hydrothorax (HH)
Beyond the preview
Go deeper on NCT03645642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645642.